323 related articles for article (PubMed ID: 26315487)
1. Multilayer-Coated Liquid Crystalline Nanoparticles for Effective Sorafenib Delivery to Hepatocellular Carcinoma.
Thapa RK; Choi JY; Poudel BK; Hiep TT; Pathak S; Gupta B; Choi HG; Yong CS; Kim JO
ACS Appl Mater Interfaces; 2015 Sep; 7(36):20360-8. PubMed ID: 26315487
[TBL] [Abstract][Full Text] [Related]
2. Active Targeting of Sorafenib: Preparation, Characterization, and In Vitro Testing of Drug-Loaded Magnetic Solid Lipid Nanoparticles.
Grillone A; Riva ER; Mondini A; Forte C; Calucci L; Innocenti C; de Julian Fernandez C; Cappello V; Gemmi M; Moscato S; Ronca F; Sacco R; Mattoli V; Ciofani G
Adv Healthc Mater; 2015 Aug; 4(11):1681-90. PubMed ID: 26039933
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
4. Intracellular interactions of electrostatically mediated layer-by-layer assembled polyelectrolytes based sorafenib nanoparticles in oral cancer cells.
Poojari R; Kini S; Srivastava R; Panda D
Colloids Surf B Biointerfaces; 2016 Jul; 143():131-138. PubMed ID: 26998875
[TBL] [Abstract][Full Text] [Related]
5. Hepatoma-targeting and pH-sensitive nanocarriers based on a novel D-galactopyranose copolymer for efficient drug delivery.
Ding Y; Han J; Tian B; Han J; Zhang J; Zheng H; Han Y; Pei M
Int J Pharm; 2014 Dec; 477(1-2):187-96. PubMed ID: 25455771
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib and gadolinium co-loaded liposomes for drug delivery and MRI-guided HCC treatment.
Xiao Y; Liu Y; Yang S; Zhang B; Wang T; Jiang D; Zhang J; Yu D; Zhang N
Colloids Surf B Biointerfaces; 2016 May; 141():83-92. PubMed ID: 26844644
[TBL] [Abstract][Full Text] [Related]
7. Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells.
Thapa RK; Youn YS; Jeong JH; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2016 Jul; 143():271-277. PubMed ID: 27022866
[TBL] [Abstract][Full Text] [Related]
8. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy.
Wang X; Zhang M; Zhang L; Li L; Li S; Wang C; Su Z; Yuan Y; Pan W
Chemistry; 2017 May; 23(27):6586-6595. PubMed ID: 28218434
[TBL] [Abstract][Full Text] [Related]
9. Biomacromolecule/lipid hybrid nanoparticles for controlled delivery of sorafenib in targeting hepatocellular carcinoma therapy.
Zhang J; Wang T; Mu S; Olerile LD; Yu X; Zhang N
Nanomedicine (Lond); 2017 Apr; 12(8):911-925. PubMed ID: 28339312
[TBL] [Abstract][Full Text] [Related]
10. Ceramide-Fabricated Co-Loaded Liposomes for the Synergistic Treatment of Hepatocellular Carcinoma.
Yin X; Xiao Y; Han L; Zhang B; Wang T; Su Z; Zhang N
AAPS PharmSciTech; 2018 Jul; 19(5):2133-2143. PubMed ID: 29714002
[TBL] [Abstract][Full Text] [Related]
11. Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma.
Tang X; Chen L; Li A; Cai S; Zhang Y; Liu X; Jiang Z; Liu X; Liang Y; Ma D
Drug Deliv; 2018 Nov; 25(1):1484-1494. PubMed ID: 29916268
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocarriers containing sorafenib inhibit colonies formation in human hepatocarcinoma cells.
Bondì ML; Botto C; Amore E; Emma MR; Augello G; Craparo EF; Cervello M
Int J Pharm; 2015 Sep; 493(1-2):75-85. PubMed ID: 26211902
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapy for human hepatic carcinoma cells using folate-functionalized polymeric micelles loaded with superparamagnetic iron oxide and sorafenib in vitro.
Zhang L; Gong F; Zhang F; Ma J; Zhang P; Shen J
Int J Nanomedicine; 2013; 8():1517-24. PubMed ID: 23620667
[TBL] [Abstract][Full Text] [Related]
14. Fabrication of poly (butadiene-block-ethylene oxide) based amphiphilic polymersomes: An approach for improved oral pharmacokinetics of Sorafenib.
Khan MA; Ali S; Venkatraman SS; Sohail MF; Ovais M; Raza A
Int J Pharm; 2018 May; 542(1-2):196-204. PubMed ID: 29551745
[TBL] [Abstract][Full Text] [Related]
15. Preparation of an efficient and safe polymeric-magnetic nanoparticle delivery system for sorafenib in hepatocellular carcinoma.
Tom G; Philip S; Isaac R; Praseetha PK; Jiji SG; Asha VV
Life Sci; 2018 Aug; 206():10-21. PubMed ID: 29709652
[TBL] [Abstract][Full Text] [Related]
16. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
[TBL] [Abstract][Full Text] [Related]
17. Receptor-targeted, drug-loaded, functionalized graphene oxides for chemotherapy and photothermal therapy.
Thapa RK; Choi JY; Poudel BK; Choi HG; Yong CS; Kim JO
Int J Nanomedicine; 2016; 11():2799-813. PubMed ID: 27358565
[TBL] [Abstract][Full Text] [Related]
18. In Vitro and In Vivo Skin Distribution of 5α-Reductase Inhibitors Loaded Into Liquid Crystalline Nanoparticles.
Madheswaran T; Baskaran R; Yoo BK; Kesharwani P
J Pharm Sci; 2017 Nov; 106(11):3385-3394. PubMed ID: 28652158
[TBL] [Abstract][Full Text] [Related]
19. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
[No Abstract] [Full Text] [Related]
20. Enhanced oral absorption of sorafenib via the layer-by-layer deposition of a pH-sensitive polymer and glycol chitosan on the liposome.
Zhao M; Lee SH; Song JG; Kim HY; Han HK
Int J Pharm; 2018 Jun; 544(1):14-20. PubMed ID: 29655795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]